{
  "identifiers": [
    {
      "type": "CUSTOM",
      "details": "reaction index",
      "value": "865"
    },
    {
      "type": "REACTION_TYPE",
      "details": "reaction type",
      "value": "1.3.1 [N-arylation with Ar-X] Bromo Buchwald-Hartwig amination"
    }
  ],
  "inputs": {
    "Base": {
      "components": [
        {
          "identifiers": [
            {
              "type": "SMILES",
              "value": "C(=O)([O-])[O-].[Cs+].[Cs+]"
            }
          ],
          "amount": {
            "moles": {
              "value": 0.000415,
              "units": "MOLE"
            }
          },
          "reaction_role": "REAGENT",
          "is_limiting": false
        }
      ]
    },
    "Solvent": {
      "components": [
        {
          "identifiers": [
            {
              "type": "SMILES",
              "value": "C1COCCO1"
            }
          ],
          "amount": {
            "volume": {
              "value": 0.006,
              "units": "LITER"
            }
          },
          "reaction_role": "SOLVENT",
          "is_limiting": false
        }
      ]
    },
    "metal and ligand": {
      "components": [
        {
          "identifiers": [
            {
              "type": "SMILES",
              "value": "CC1(C2=C(C(=CC=C2)P(C3=CC=CC=C3)C4=CC=CC=C4)OC5=C1C=CC=C5P(C6=CC=CC=C6)C7=CC=CC=C7)C"
            }
          ],
          "amount": {
            "moles": {
              "value": 4.15e-05,
              "units": "MOLE"
            }
          },
          "reaction_role": "CATALYST",
          "is_limiting": false
        },
        {
          "identifiers": [
            {
              "type": "SMILES",
              "value": "C1=CC=C(C=C1)/C=C/C(=O)/C=C/C2=CC=CC=C2.C1=CC=C(C=C1)/C=C/C(=O)/C=C/C2=CC=CC=C2.C1=CC=C(C=C1)/C=C/C(=O)/C=C/C2=CC=CC=C2.[Pd].[Pd]"
            }
          ],
          "amount": {
            "moles": {
              "value": 2.08e-05,
              "units": "MOLE"
            }
          },
          "reaction_role": "CATALYST",
          "is_limiting": false
        }
      ]
    },
    "aryl halide": {
      "components": [
        {
          "identifiers": [
            {
              "type": "SMILES",
              "value": "CC1(C2=NC(=C(N2CCN1C(=O)CNC(=O)OC(C)(C)C)Br)C3=CC=C(C=C3)F)C"
            }
          ],
          "amount": {
            "moles": {
              "value": 0.000415,
              "units": "MOLE"
            }
          },
          "reaction_role": "REACTANT",
          "is_limiting": false
        }
      ]
    },
    "amine": {
      "components": [
        {
          "identifiers": [
            {
              "type": "SMILES",
              "value": "C1=CC(=CC=C1N)F"
            }
          ],
          "amount": {
            "moles": {
              "value": 0.000831,
              "units": "MOLE"
            }
          },
          "reaction_role": "REACTANT",
          "is_limiting": false
        }
      ]
    }
  },
  "conditions": {
    "temperature": {
      "setpoint": {
        "value": 120.0,
        "precision": 10.0,
        "units": "CELSIUS"
      }
    }
  },
  "notes": {
    "procedure_details": "In a microwave vial, cesium carbonate (135 mg, 0.42 mmol), 4-fluoroaniline (92 mg, 0.83 mmol), tris(dibenzylideneacetone)dipalladium(0) (19.02 mg, 0.02 mmol), Xantphos (24.04 mg, 0.04 mmol) and dry 1,4-dioxane (6 mL) were stirred for 5 minutes at room temperature. tert-butyl (2-(3-bromo-2-(4-fluorophenyl)-8,8-dimethyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)-2-oxoethyl)carbamate (200 mg, 0.42 mmol) was added to the reaction mixture after which the reaction mixture was degassed for 15 mins and then stirred at 120 Â°C under N2 for 20 h.  The reaction was monitored by LCMS. The profile showed formation of title product.    The reaction mixture was filtered through a pad opf celite and the filtrate was concentrated to give a residue. The residue was purified by silica gel followed by reverse phase HPLC to give tert-butyl (2-(2-(4-fluorophenyl)-3-((4-fluorophenyl)amino)-8,8-dimethyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)-2-oxoethyl)carbamate (177 mg, 83 %) as a white solid.  Conclusion:  The product was used for the next step.  "
  },
  "outcomes": [
    {
      "products": [
        {
          "identifiers": [
            {
              "type": "SMILES",
              "value": "CC1(C2=NC(=C(N2CCN1C(=O)CNC(=O)OC(C)(C)C)NC3=CC=C(C=C3)F)C4=CC=C(C=C4)F)C"
            }
          ],
          "is_desired_product": true,
          "measurements": [
            {
              "type": "YIELD",
              "percentage": {
                "value": 83.27
              }
            }
          ],
          "reaction_role": "PRODUCT"
        }
      ]
    }
  ],
  "provenance": {
    "experimenter": {
      "organization": "AstraZeneca"
    },
    "experiment_start": {
      "value": "11/07/2013"
    },
    "publication_url": "https://chemrxiv.org/engage/chemrxiv/article-details/60c9e3f37792a23bfdb2d471",
    "record_created": {
      "time": {
        "value": "10/19/2021, 12:16:25 PM"
      },
      "person": {
        "name": "Bozhao Nan",
        "organization": "Notre Dame",
        "email": "bnan@nd.edu"
      }
    },
    "record_modified": [
      {
        "time": {
          "value": "Fri Oct 22 22:19:55 2021"
        },
        "person": {
          "username": "github-actions",
          "email": "github-actions@github.com"
        },
        "details": "Automatic updates from the submission pipeline."
      }
    ]
  },
  "reaction_id": "ord-be476d7266d0479ba1e6c4f9e5b26400"
}